An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression.

Khan, Aamir Ali; Liu, Xinhui; Yan, Xinlong; Tahir, Muhammad; Ali, Sakhawat; Huang, Hua

Khan, Aamir Ali; Liu, Xinhui; Yan, Xinlong; Tahir, Muhammad; Ali, Sakhawat; Huang, Hua.

Afiliação

Khan AA; College of Life Science and Bioengineering, Beijing University of Technology, 100 Ping Le Yuan, Chaoyang, Beijing, 100124, China.
Liu X; College of Life Science and Bioengineering, Beijing University of Technology, 100 Ping Le Yuan, Chaoyang, Beijing, 100124, China.
Yan X; College of Life Science and Bioengineering, Beijing University of Technology, 100 Ping Le Yuan, Chaoyang, Beijing, 100124, China. yxlong2000@bjut.edu.cn.
Tahir M; College of Life Science and Bioengineering, Beijing University of Technology, 100 Ping Le Yuan, Chaoyang, Beijing, 100124, China.
Ali S; College of Life Science, Beijing Institute of Technology, 5 South Zhongguancun Street, Haidian District, Beijing, 100081, China.
Huang H; College of Life Science and Bioengineering, Beijing University of Technology, 100 Ping Le Yuan, Chaoyang, Beijing, 100124, China. Huangh@bjut.edu.cn.

Cancer Metastasis Rev ; 40(1): 245-272, 2021 03.

Article em En | MEDLINE | ID: mdl-33423164

Assuntos

Epigênese Genética; Mutação; Neoplasias Pancreáticas; Homozigoto; Humanos; Neoplasias Pancreáticas/genética; Deleção de Sequência

Palavras-chave

Aberrant epigenetic signature; Aberrant hypermethylation; CDKN2A; KRAS; Pancreatic cancer; SMAD4; p53

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google